Asubio Corporate History
| 1979 | The Pharmaceutical Division of Suntory Ltd. establishes Suntory Institute For Biomedical Research.
............................................. |
| 1980-1990 | New drug candidates discovered through research into leading-edge technologies. ............................................. |
| 1991 | Launch of SUNRYTHM®, an anti-arrhythmic agent; the first drug developed by Suntory and the first anti-arrhythmic agent produced in Japan.
............................................. |
| 1992 | Japanese launch of BIOPTEN® (Tetrahydrobiopterin), a pharmaceutical agent for the treatment of congenital metabolic abnormalities. Japanese launch of BIOGAMMA®, an anti-cancer agent. ............................................. |
| 1995 | Japanese launch of HANP® (human atrial natriuretic peptide) for acute heart failure. ............................................. |
| 1997 | Japanese launch of the penem-type antibiotic FAROM® tablet.
............................................. |
| 1999 | Established Suntory Pharmaceutical, Inc. in Fort Lee, New Jersey for clinical development in the United States and Europe. ............................................. |
| 2001 | Developed recombinant human GLP-1 (glucagon like peptide-1), anti-type II diabetes,
with nasal formulation.
............................................. |
| 2002 | Daiichi Pharmaceutical Co., Ltd. and Suntory Ltd. agree to establish a new partnership, Daiichi Suntory Pharma Co., Ltd. in Japan. ............................................. |
| 2004 | Suntory Pharmaceutical, Inc. becomes Daiichi Asubio Pharmaceuticals, Inc.
............................................. |
| 2005 | In February 2005, Daiichi Pharmaceutical Co., Ltd. and Sankyo Co., Ltd. announced an agreement to merge into a new company, Daiichi Sankyo Co., Ltd. ............................................. |
| 2005 | Completion of a new Bio-Plant which is a multi-product and multi-scale “Launch Plant” for bio bulk products in the BioPharma Center in Gunma, Japan.
............................................. |
| 2007 | Change of company name to Asubio Pharma Co., Ltd. in Japan and Asubio Pharmaceuticals, Inc. in US. |
| Back To top |